Suppr超能文献

原代小胶质细胞的M1和M2功能印记:P2X7激活和miR-125b的作用

M1 and M2 Functional Imprinting of Primary Microglia: Role of P2X7 Activation and miR-125b.

作者信息

Parisi Chiara, Napoli Giulia, Pelegrin Pablo, Volonté Cinzia

机构信息

CNR-Institute of Cell Biology and Neurobiology, Via del Fosso di Fiorano 65, 00143 Rome, Italy; Fondazione Santa Lucia, Via del Fosso di Fiorano 65, 00143 Rome, Italy.

Fondazione Santa Lucia, Via del Fosso di Fiorano 65, 00143 Rome, Italy.

出版信息

Mediators Inflamm. 2016;2016:2989548. doi: 10.1155/2016/2989548. Epub 2016 Dec 20.

Abstract

Amyotrophic lateral sclerosis (ALS) is a most frequently occurring and severe form of motor neuron disease, causing death within 3-5 years from diagnosis and with a worldwide incidence of about 2 per 100,000 person-years. Mutations in over twenty genes associated with familial forms of ALS have provided insights into the mechanisms leading to motor neuron death. Moreover, mutations in two RNA binding proteins, TAR DNA binding protein 43 and fused in sarcoma, have raised the intriguing possibility that perturbations of RNA metabolism, including that of the small endogenous RNA molecules that repress target genes at the posttranscriptional level, that is, microRNAs, may contribute to disease pathogenesis. At present, the mechanisms by which microglia actively participate to both toxic and neuroprotective actions in ALS constitute an important matter of research. Among the pathways involved in ALS-altered microglia responses, in previous works we have uncovered the hyperactivation of P2X7 receptor by extracellular ATP and the overexpression of miR-125b, both leading to uncontrolled toxic M1 reactions. In order to shed further light on the complexity of these processes, in this short review we will describe the M1/M2 functional imprinting of primary microglia and a role played by P2X7 and miR-125b in ALS microglia activation.

摘要

肌萎缩侧索硬化症(ALS)是运动神经元疾病中最常见且最严重的一种形式,患者从确诊起3至5年内会死亡,全球发病率约为每10万人年2例。与家族性ALS相关的二十多个基因发生突变,这为深入了解导致运动神经元死亡的机制提供了线索。此外,两种RNA结合蛋白——TAR DNA结合蛋白43和肉瘤融合蛋白发生突变,引发了一种有趣的可能性,即RNA代谢紊乱,包括在转录后水平抑制靶基因的小内源性RNA分子(即微小RNA)的代谢紊乱,可能参与了疾病的发病机制。目前,小胶质细胞在ALS中如何积极参与毒性和神经保护作用的机制是一个重要的研究课题。在与ALS相关的小胶质细胞反应改变的诸多途径中,我们在之前的研究中发现细胞外ATP会使P2X7受体过度激活,以及miR-125b过表达,这两者都会导致失控的毒性M1反应。为了进一步阐明这些过程的复杂性,在这篇简短的综述中,我们将描述原代小胶质细胞的M1/M2功能印记以及P2X7和miR-125b在ALS小胶质细胞激活中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1332/5206439/a7c6d252fd5d/MI2016-2989548.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验